None listed
Conditions
Interventions
Intervention1: intranasal corticosteroids: intranasal steroids without Jalneti
Intervention2: medical management with intranasal corticosteroids and antihistaminics with jalneti: medical management wi
Sponsors
Armed Forces Medical collegePune
Eligibility
Inclusion criteria
Inclusion criteria: 1. All freshly diagnosed cases of allergic rhinitis of 18-60 years of age 2.All patients of mild and moderately-severe allergic rhinitis(ARIA guidelines)
Exclusion criteria
Exclusion criteria: 1.Patients who has grade III nasal septal deviation, active nasal bleeding, or recent nasal surgery. 2.Patients who are immunocompromised i.e. Diabetes, HIV,cancer,organ transplant patients,autoimmune diseases etc 3.Syndromic patients like churg strauss syndrome, kartagener syndrome etc 4.Patients with polyps and mucocele that obstructs the sinuses. 5.All children less than 15yrs of age and adults above 60 years age(safety issues in learning technique)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the efficacy of Jalneti as an adjunct treatment of Allergic Rhinitis in patients undergoing medical management with intranasal corticosteroids and antihistaminics.Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| . To subjectively know the impact of Jalneti on the quality of life using sinonasal outcome test scores.Timepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr Jobanpreet Singh
Department of ENT, Armed Forces Medical College, PUNE
Outcome results
None listed